DCM
PLRX icon

Dupont Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Dupont Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,850
Closed -$545K – 1811
2021
Q1 		$545K Buy
13,850
+1,971
+17% +$64K 0.01% 873
2020
Q4 		$270K Sell
11,879
-387
-3% -$9.7K 0.01% 1066
2020
Q3 		$278K Buy
+12,266
New +$307K 0.01% 1002

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Dupont Capital Management's PLRX Position: Q2 2021 in Review

Dupont Capital Management sold out of Pliant Therapeutics (PLRX) in Q2 2021, closing a stake of 13,850 shares — an estimated $545K sold.

Dupont Capital Management first reported a position in PLRX in Q3 2020 and held it in 3 quarters. The position peaked at $545K in Q1 2021. 81 funds tracked by Wall St. Rank hold PLRX as of Q2 2021.

  • Dupont Capital Management reported no remaining Pliant Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Dupont Capital Management sold 13,850 Pliant Therapeutics shares in Q2 2021, an estimated $545K.
  • Dupont Capital Management first reported a position in Pliant Therapeutics in Q3 2020 and held it in 3 quarters.
  • Dupont Capital Management's Pliant Therapeutics position peaked at $545K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.